Abstract -Vaccination is an effective strategy to prevent leptospirosis, a global zoonotic disease caused by infection with pathogenic Leptospira species. However, the currently used multiple-valence vaccine, which is prepared with whole cells of several Leptospira serovars, has major side effects, while its cross-immunogenicity among different Leptospira serovars is weak. LipL32, LipL21 and OmpL1 have been confirmed as surface-exposed antigens in all pathogenic Leptospira strains, but their immunoprotective efficiency needs to be improved. In the present study, we generated a fusion gene lipL32/1-lipL21-ompL1/2 using primer-linking PCR and an engineered E. coli strain to express the recombinant fusion protein rLipL32/1-LipL21-OmpL1/2 (rLLO). Subsequently, the expression conditions were optimized using a central composite design that increased the fusion protein yield 2.7-fold. Western blot assays confirmed that rLLO was recognized by antirLipL32/1, anti-rLipL21, and anti-rOmpL1/2 sera as well as 98.5% of the sera from leptospirosis patients. The microscopic agglutination test (MAT) demonstrated that rLLO antiserum had a stronger ability to agglutinate the strains of different Leptospira serovars than the rLipL32/1, rLipL21, and rOmpL1/2 antisera. More importantly, tests in hamsters showed that rLLO provided higher immunoprotective rates (91.7%) than rLipL32/1, rLipL21 and rOmpL1/2 (50.0-75.0%). All the data indicate that rLLO, a recombinant fusion protein incorporating three antigens, has increased antigenicity and immunoprotective effects, and so can be used as a novel immunogen to develop a universal genetically engineered vaccine against leptospirosis.
INTRODUCTION
Leptospirosis is a global zoonotic disease in both humans and animals caused by infection with pathogenic Leptospira species (Bharti et al., 2003) . Human leptospirosis is prevalent in East/Southeast Asia and South America (Ricaldi et al., 2013) . However, in recent years, human leptospirosis cases have been frequently reported in Europe, North America, and Africa, where it is considered an emerging or re-emerging infectious disease (Vijayachari et al., 2008; Hartskeerl et al., 2011; Dupouey et al., 2014) . Thus, this disease has become a public health problem of global importance (Pappas et al., 2008) .
Many animals, including dogs and livestock have been confirmed as the natural hosts of pathogenic Leptospira species. Infected animals usually display a mild or symptomless persistent infection but discharge leptospires through their urine for long periods that contaminate soil and natural bodies of water (Adler et al., 2010) . Humans suffer from leptospirosis after contact with leptospire-contaminated soil and water (McBride et al., 2005) . Pathogenic Leptospira species rapidly enter the blood stream after invading the body through the skin and mucosa and then promptly spread to the lungs, liver, and kidneys, where they cause tissue injury (Adler et al., 2010; McBride et al., 2005; Dassanayake et al., 2012) . The course of leptospirosis in humans varies from mild to rapidly fatal forms, including influenza-like manifestations such as fever and myalgia, and severe symptoms such as respiratory failure due to diffuse pulmonary hemorrhage and meningitis, and renal failure caused by renal injury and serious jaundice (McBride et al., 2005; Dassanayake et al., 2012; De Brito et al., 2013) . Pathogenic Leptospira species have been classified into seven genospecies: L. interrogans, L. borgpetersenii, L. kirschneri, L. noguchii, L. santarosai, L. meyeri, and L. weilii (Adler et al., 2010; Hu et al., 2014) . However, L. interrogans, which has been serologically divided into about 230 serovars belonging to 23 serogroups, is the predominant pathogenic genospecies in most countries and areas in the world, including China (Forbes et al., 2012; Miraglia et al., 2013; Sakundarno et al., 2014; Zhang et al., 2012) .
Vaccination is an effective strategy to prevent infectious diseases. Since there is a geographical diversity of predominant L. interrogans serovars and major animal carriers, and since the cross-immunogenicity among different L. interrogans serovars is weak, the currently used leptospirosis vaccine is prepared with killed whole cells of the 3-5 L. interrogans serovars prevailing in local areas (Fitzgerald et al., 2009; Verma et al., 2013 ). However, currently vaccines against leptospirosis are of low efficacy, have an unacceptable side-effect profile, and provide no cross-protection against the different serovars of pathogenic leptospires. ( Fitzgerald et al., 2009; Verma et al., 2013; Srikram et al. 2008 ). More importantly, the vaccine does not provide immunogenicity for individuals infected with L. interrogans serovars that are not included in the vaccine (Hu et al., 2014; Zhang et al., 2012) . Therefore, a new vaccine with extensive cross-immunogenicity and minimal side effects would greatly contribute to the prevention and control of leptospirosis.
Leptospiral membrane proteins can act as protective antigens in experimental animals given a lethal challenge of L. interrogans (Atzingen et al., 2010) . Previous studies have revealed that membrane proteins such as OmpL1, LipL21, LipL32, LipL41, LipL46, LenA, Loa22, and LigB are only expressed in pathogenic Leptospira species (Haake et al. 1993; Haake et al., 2000; Shang et al., 1996; Cullen et al., 2003; Matsunaga et al., 2006; Verma et al., 2010; Ristow et al., 2007; Matsunaga et al., 2003) . However, our previous studies confirmed that the lipL32, lipL41, and ompL1 but not the lipL21 genes in 15 strains belonging to 15 serovars in 15 serogroups of pathogenic L. interrogans, L. borgpetersenii, and L. weilii in China have different genotypes (lipL32/1 and lipL32/2, lipL41/1 and lipL41/2, and ompL1/1, ompL1/2, and ompL1/3), but the major predominant L. interrogans serovars in China express OmpL1/2-and LipL32/1-type proteins (Dong et al., 2008; Luo et al., 2009 ). Compared to recombinant OmpL1, LipL21 and LipL32, recombinant LipL41 has been shown to provide less immunogenicity in guinea-pigs (Dong et al., 2008; Luo et al., 2009) . Therefore, the LipL21, OmpL1/2, and LipL32/1 proteins of L. interrogans have potential use for developing a new universal genetically engineered vaccine against leptospirosis.
Prokaryotic microbes including Leptospira possess a much more complicated antigenic composition than viruses (Nally et al., 2007) . In our view, the use of multiple-protein antigens as the immunogen will improve the immunoprotective effect of genetically engineered vaccines against leptospirosis. In the present study, we generated a fusion gene lipL32/1-lipL21-ompL1/2 and its prokaryotic expression system. The cross-immunoreactivity and immunogenicity in hamsters of the recombinant triple-protein antigen expressed by this fusion gene were subsequently determined. Moreover, the expression conditions of the triple-protein antigen were optimized.
MATERIALS AND METHODS

Leptospiral strains and culture
Fifteen strains belonging to 15 serovars in 15 serogroups of three pathogenic Leptospira genospecies (Table 1) , which are prevalent in China and officially used as the standard strains for serological diagnosis of Chinese leptospirosis patients, were provided by the Chinese National Institute for Control of Pharmaceutical and Biological Products (Table 1) . The strains were cultured in Ellinghausen-McCullough-Johnson-Harris (EMJH) liquid medium at 28°C (Zhao et al., 2013) . L. interrogans serogroup Icterohaemorrhagiae serovar Lai strain Lai, serogroup Grippotyphosa serovar Grippotyphosa strain Lin-6, and serogroup Pomona serovar Pomona strain Luo used in animal protective test were maintained by serial passage in hamsters to preserve virulence.
Serum samples
Serum samples from 133 leptospirosis patients with microscopic agglutination test (MAT) titers >1:100 collected in the last three years were provided by the Centers of Disease Prevention and Control of Sichuan, Jiangxi and Zhejiang Provinces in China (Table 1). Serum samples from 12 individuals without antibodies against Leptospira as determined by MAT collected during routine health examination were provided by the Affiliated Hospitals of Zhejiang University School of Medicine. The collection of serum samples was approved by the Research Ethics Committee of Zhejiang University School of Medicine and informed written consent for sample collection was given by all participants.
Animals
New Zealand rabbits (3.2 to 3.5 kg) and male Syrian hamsters (25 ± 2 g, 4 weeks old) were provided by the Experimental Animal Center of Zhejiang University. The experimental protocols were approved by the Animal Ethics Committee of Zhejiang University School of Medicine.
Amplification and sequencing of target leptospiral genes
Genomic DNA from L. interrogans serogroup Icterohaemorrhagiae serovar Lai strain Lai was extracted using a bacterial DNA extraction kit (BioColor, China). In order to decrease the size of the lipL32/1, lipL21, and ompL1/2 fusion gene to enhance the recombinant fusion protein expression in the next experiment, the signal peptide sequence-free lipL21 gene (49-558 bp) and transmembrane sequence-free lipL32/1 and ompL1/2 genes (58-816 and 73-960 bp) were amplified by PCR from the leptospiral DNA using the primers P1F/P1R, P2F/P2R, and P3F/ P3R ( Table 2 ). The P1R, P2F, P2R, and P3F primers contained a flexible peptide (GGGGSGGGGSGG-GGS)-encoding sequence at the 5' terminals and this sequence was not only used to link the three genes but was also beneficial for maintaining the independent immunogenicity of the LipL32/1, LipL21 and OmpL1/2 segments in the fusion protein. The products were examined on 1.5% ethidium bromide pre-stained agarose gel after electrophoresis and then cloned into pUC18-T plasmid to form pUC18-T
, and pUC18-T ompL1/2 using a T-A cloning kit (TaKaRa, China) for sequencing by Invitrogen Co.,Shanghai, China.
Generation and identification of lipL32/1-lipL21-ompL1/2 fusion gene
The leptospiral lipL32/1, lipL21, and ompL1/2 genes were amplified by PCR as above. The PCR products were extracted using a PCR Product Purification Kit (Axygen, USA), and then quantified by ultraviolet spectrophotometry (Xue et al., 2010) . A special PCR was performed to generate the lipL32/1-lipL21-ompL1/2 fusion gene. The reactive mixture contained all the PCR reagents, except for the primers, using 100 ng DNA from each of the extracts as the template. The reaction was initiated at 94°C for 5 min and then repeated at 94°C for 1 min, 45°C for 1 min, and 72°C for 3 min for 10 cycles to form a combined template lipL32/1-lipL21-ompL1/2 (a 2247-bp segment including 759-bp lipL32/1, 510-bp lipL21, and 888-bp ompL1/2 plus two 45-bp flexible peptide linker sequences) (Table 2 ). Subsequently, the primers P1F and P3R (Table 2) were added to the mixture for 30 cycles of amplification at 52°C annealing temperature. The agarose gel electrophoresis, T-A cloning, and sequencing of the amplified lipL32/1-lipL21-ompL1/2 fusion gene were performed as described above. ). This strain was cultured in kanamycin-containing Luria-Bertani (LB) liquid medium (Oxoid, UK). The pET42a lip-L32/1-lipL21-ompL1/2 was extracted from the culture using a Plasmid MiniPrep Kit (Axygen) for re-sequencing.
Generation
Expression and extraction of leptospiral recombinant proteins
The engineered E. coli BL21DE3
, and E. coli BL21DE3
were from our laboratory (Dong et al., 2008; Luo et al., 2009) . Under induction by 1 mM isopropyl-β-D-thiogalactoside (IPTG) (Sigma, USA), the target recombinant proteins rLipL32/1, rLipL21, rOmpL1/2, and rLipL32/1-LipL21-OmpL1/2 (rLLO) were expressed by the three engineered strains and
, respectively. The expressed recombinant proteins were extracted using an Ni-NTA affinity chromatographic column (BioColor). The yield and purity of the recombinant proteins were estimated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) with a Gel Image Analyzer (BioRad, USA).
Optimization of rLLO expression conditions
To increase the yield of rLLO, a central composite design (CCD) from response surface methodology was applied to optimize the expression conditions such as initial pH, dose of IPTG, duration before and after induction, and induction temperature. The details of the experiments are shown in the Supplementary Materials.
Preparation of rLLO antiserum
Rabbits were intradermally immunized on days 1, 10, 20 and 30 with 2 mg per animal of rLLO premixed with Freund's adjuvant. Fifteen days after the last immunization, the serum was collected. Immunodiffusion test was used to assess the titer of antiserum binding to the recombinant fusion protein.
Western blot analysis
The protein concentrations in the leptospiral rLipL32/1, rLipL21, rOmpL1/2, and rLLO extracts were determined using a BCA Protein Quantitative Kit (Beyotime Biotech, China) (Wang et al., 2012) . After SDS-PAGE, the recombinant proteins (10 μg each) in gels were electron-transferred onto PVDF membrane (Millipore, USA). Using 1:1000 diluted rabbit anti-rLLO serum as the primary antibody and 1:3000 diluted HRP-labeled goat anti-rabbit IgG (ImmunoResearch, USA) as the secondary antibody, Western blot assays were applied to determine the combination of the recombinant protein antigens with antiserum. In addition, several Western blot assays were performed using rabbit antisera against rLipL32/1, rLipL21, and rOmpL1/2, and against whole cells of L. interrogans serogroup Icterohaemorrhagiae serovar Lai strain Lai, serogroup Grippotyphosa serovar Grippotyphosa strain Lin-6, serogroup Autumnalis serovar Autumnalis strain Lin-4, serogroup Pomona serovar Pomona strain Luo, L. borgpetersenii serogroup Javanica serovar Javanica strain M-10, and L. weilii sero-group Manhao serovar Manhao 2 strain L-105 as the primary antibody to detect rLLO as above. The antisera against rLipL32/1, rLipL21, rOmpL1/2 and the whole cells of different Leptospira strains were made in our laboratory (Dong et al., 2008; Luo et al., 2009) .
Microscopic agglutination test
MAT is a typical serological method to diagnose leptospirosis in humans and animals using living leptospires to detect specific agglutination antibodies in serum (Dong et al., 2008; Luo et al., 2009) . Briefly, the rLipL32/1, rLipL21, rOmpL1/2, and rLLO antisera were double-diluted with 0.01 M phosphate-buffered saline (PBS, pH 7.4). Each of the dilutions (0.1 ml) was mixed with 0.1 ml of each of the cultures of fifteen standard leptospiral strains (Table 1) . The mixtures were incubated at 37°C for 1 h and agglutination was assessed under a dark-field microscope (400×). The highest dilution of antiserum that agglutinated 50% of leptospires was considered the terminal MAT titer (Luo et al., 2009 ). In the MAT, sera from three normal rabbits were mixed and served as the control. ELISA rLipL32/1, rLipL21, rOmpL1/2, and rLLO were diluted with 0.01 M carbonate sodium buffer (pH 9.6). One hundred microliters per well of each of the recombinant protein solutions (20 µg/ml) was loaded in 96-well polystyrene plates for overnight incubation at 4°C. The plates were thoroughly washed with 0.05% Tween 20-PBS and then blocked with 10% BSA-PBS. Using 1:100 diluted sera from 133 leptospirosis patients (Table 1) as the primary antibody and 1:3000 diluted HRP-labeled goat anti-human-IgG (ImmunoResearch) as the secondary antibody, ELISA was performed to determine the optical density at 490 nm (OD 490 ) per well using a microplate reader (BioRad). In the ELISA, the sera from 12 healthy MAT-negative individuals were used as the negative control. If the OD 490 of a patient's serum sample was higher than the mean plus three-fold standard deviation (SD) of the negative control, the result was regarded as positive (Lewis et al., 2003) .
Immunoprotective test in hamsters
Hamsters were intraperitoneally injected with 1×10 5 , 5×10 5 , 1×10 6 , 5×10 6 , 1×10 7 , 5×10 7 , or 1×10 8 of L. interrogans serovar Lai strain Lai, serovar Grippotyphosa strain Lin-6, or serovar Pomona strain Luo, and eight animals were used per group (Kassegne et al., 2014) . Eight negative control animals were intraperitoneally injected with EMJH medium. The animals were monitored twice daily and their survival was recorded within 14 days after challenge to obtain the minimal lethal dose of all animal deaths in a group (100% MLD). Fifteen groups of hamsters (A1-3, B1-3, C1-3, D1-3, and E1-3) were subcutaneously immunized twice at a weekly interval with 200 μg rLipL32, rLipL21, rOmpL1/2, rLLO, or a mixture of equimolar rLipL32/1, rLipL21, and OmpL1/2 (1:1:1) using 1 mg aluminum hydroxide (Sigma) as the adjuvant. In addition, another three groups of hamsters (E1-3) were immunized with 200 μg BSA (Sigma) as above and served as the control. On the fifteenth day after the last immunization, the immunized hamsters were intraperitoneally injected with double the 100% MLD of strain Lai, Lin-6, or Luo (10 6 , 10 7 , or 10 7 leptospires) as above. The animals were monitored twice daily and their death/survival was recorded within two weeks after challenge. The χ 2 test was used to determine significant differences among the percentages of immunogenicity. Statistical significance was defined as p <0.05.
Pathological examination and leptospiral isolated culture
Liver, lung and kidney samples from the hamsters that had died or survived in the immunoprotective test were fixed, embedded, sectioned and HE-stained as previously described (Kassegne et al., 2014) . Pathological changes in the samples were observed under a light microscope. In addition, 2-3 small pieces (~3×3 mm) of each of the kidney samples was inoculated in EMJH medium for 21-day incubation at 28°C and then examined by dark-field microscopy.
RESULTS
PCR and sequencing results
PCR showed that the lipL32/1-lipL21-ompL1/2 fusion gene was generated using the flexible peptide sequence-based primers (Fig. 1A) . The sequencing data confirmed that the generated lipL32/1-lipL21-ompL1/2 fusion gene had the same sequences as the three separate lipL32/1, lipL21 and ompL1/2 genes (GenBank Nos: GI7330696, GI 30171159, and GI 348937).
Optimal expression conditions for rLLO
After induction by IPTG, the rLipL32/1, rLipL21, and rOmpL1/2 were efficiently expressed (Fig. 1B) . However, the yield (37.78 mg/L) of rLLO under optimal expression conditions (initial pH 7.9, 0.2 mM IPTG, 2.5 h duration before induction, 5.83 h duration after induction, and 31°C induction temperature) was markedly higher than that of 13.95 mg/L under routine expression conditions (initial pH 7.4, 1 mM IPTG, 2 h duration before induction, 4 h duration after induction, and 37°C induction temperature) (Fig. 1C) . Besides, each of the recombinant proteins extracted by Ni-NTA affinity chromatography showed a single band on gels (Fig. 1B and C) . The details of the optimal expression of rLLO are shown in the Supplementary Materials.
Effective combination between recombinant proteins and antisera
Western blot assays demonstrated that the rLLO antiserum combined with rLipL32/1, rLipL21, rOmpL1/2 and rLLO ( Fig. 2A) , while the rLipL32/1, rLipL21 and rOmpL1/2 antisera also recognized rLLO (Fig. 2B ). More importantly, rLLO gave positive immunoblotting results with the antisera against four strains from different serogroups or serovars of L. interrogans and two strains belonging to L. borgpetersenii and L. weilii (Fig. 2C) Expressed and extracted rLipL32/1, rLipL21, and rOmpL1/2. Lane M, protein marker (BioColor); lanes 1, 4, and 7 / 3, 6, and 9, expressed / extracted rLipL32/1, rLipL21, and rOmpL1/2 (~29.1, 19.6, and 34.0 kDa), respectively; lanes 2, 5, and 8, wild-type pET42a-transformed E. coli strain used as control. (C) Higher yield of rLLO under optimal expression conditions. Lane M, protein marker (BioColor); lanes 1 and 2, rLLO (~86.1 kDa) expressed under the optimal expression conditions (lane 2) was higher than that under the routine expression conditions (lane 1); lane 3, wild-type pET42a-transformed E. coli strain used as control; lanes 4 and 5, rLLO extracted from the same volume of culture under routine and optimal expression conditions by Ni-NTA affinity chromatography.
probably express the LipL32, LipL21 and OmpL1 proteins.
Cross-agglutination of rLLO antiserum with different leptospiral strains
The MAT confirmed that the rLLO antiserum agglutinated all the 15 standard strains belonging to 15 serovars in 15 serogroups of L. interrogans, L. borgpetersenii and L. weilii with 1:100 to 1:400 titers (Table 3 ). The MAT titers of rLLO antiserum against 7 strains of L. interrogans (1:200-1:400) and 1 strain of L. borgpetersenii (1:200) were higher (1:100-1:200 and 1:100) than those of rLipL32/1, rLipL21 and rOmpL1/2 antisera (Table 3 ). These data suggested that LipL32/1, LipL21, and OmpL1 are common antigens of pathogenic Leptospira genospecies, and the rLLO antiserum has a more powerful cross-agglutinative effect, probably due to its multiple binding sites.
High positive rates of anti-rLLO antibody ELISA in sera from leptospirosis patients
The cut-off value (mean OD 490 + 3×SD) in ELISA from the sera of Leptospira antibody-negative healthy individuals was 0.22. Based on the cut-off value, 98.5% (131/133) of the sera from 133 patients infected with L. interrogans serogroup Icterohaemorrha- No significant difference was found between the immunoprotective rates in the hamsters immunized with rLLO and those immunized with the mixture of equimolar rLipL32/1, rLipL21, and rOmpL1/2 (χ 2 = 0.56, p >0.05). BSA was used as the control and all the BSA-immunized hamsters died after challenge. *p <0.05 vs. immunoprotective rates in hamsters immunized with the same concentrations of single rLipL32/1, rLipL2, or rOmpL1/2; χ 2 = 4.60, 13.57, and 6.70).
giae serovar Lai (n = 60), serogroup Grippotyphosa serovar Grippotyphosa (n = 31), serogroup Pomona serovar Pomona (n = 30) and serogroup Autumnalis serovar Autumnalis (n = 12) were positive (Table 4) . Only two serum samples, from patients infected with serovar Lai and serovar Pomona, showed negative results. These data suggested that LipL32/1, LipL21 and/or OmpL1/2 are dominant antigens of L. interrogans that induce specific antibodies in patients.
Strong immunoprotective effect of rLLO in hamsters
All the BSA-immunized hamsters (control) died after challenge with a lethal dose of L. interrogans serovar Lai strain Lai, serovar Grippotyphosa strain Lin-6 or serovar Pomona strain Luo. However, immunization with rLLO provided higher rates of immunogenicity (91.7%) after challenge than immunization with the same concentration of single rLipL32/1, rLipL21 or rOmpL1/2 (66.7-75.0%, 50.0-58.3%, and 66.7%; χ 2 = 4.60, 13.57 and 6.70; p <0.05) ( Table 5 and Fig.  3) . However, the immunoprotective rate in hamsters immunized by a mixture of equimolar single rLipL32/1, rLipL21 and OmpL1/2 (83.3-91.7%) was similar to that in hamsters immunized with rLLO (χ 2 = 0.56, p >0.05). In addition, the dark-field micro- Fig. 4 . Diversity of pathological damage in immunized and non-immunized hamsters after infection with L. interrogans (HE stain). The hamsters killed by infection with L. interrogans displayed serious diffuse hemorrhage in the lung, extensive hepatocyte necrosis in the liver, and serious congestion and focal epithelial cell necrosis in the kidney, but the surviving hamsters immunized with rLLO exhibited slight pulmonary hemorrhage, and mild hepatic and renal congestion. scopic examination showed that no leptospires were found in any of the cultures of kidney samples from surviving hamsters (n = 133), while 71.1% (59/83) of the cultures from dead hamsters displayed leptospire growth.
Pathological changes in hamsters after infection with L. interrogans.
Pathological examination showed that the hamsters killed by infection with L. interrogans displayed serious diffuse pulmonary hemorrhage, extensive hepatocyte necrosis and serious renal congestion and focal epithelial cell necrosis, while the surviving hamsters immunized with rLLO exhibited mild pathological injury (Fig. 4) .
DISCUSSION
Pathogenic L. interrogans comprise a large group of heterogenic spirochetes that includes at least 230 serovars belonging to 23 serogroups with a large and diverse distribution in different regions of the world (Pappas et al., 2008; Adler et al., 2010; McBride et al., 2005) . For instance, L. interrogans serovar Lai or Copenhageni is predominant in China, Europe and Brazil (Forbes et al., 2012; Miraglia et al., 2013; Zhang et al., 2012) , while pathogenic L. santarosai serovar Shermani is prevalent in Taiwan (Chou et al., 2012) . On the other hand, the numerous serovars of L. interrogans indicate the diversity of antigens on their surface. This is why the currently used wholecell leptospirosis vaccine is composed of several L. interrogans serovars. However, this vaccine is limited in application due to the LPS-based adverse reaction and the weak cross-immunogenicity among different L. interrogans serovars (Verma et al., 2013) . For instance, at the turn of the 21st century, L. interrogans serogroup Sejroe serovar Medanesis caused several outbreaks in South China, but vaccination with a triple whole-cell vaccine composed of L. interrogans serovars Lai, Grippotyphosa and Autumnalis had no immunoprotective effect (Hu et al., 2014) . Thus, the development of universal vaccines with minimal side effects is crucial for the further prevention and control of human leptospirosis.
LPS-free, protein antigen-based and genetically engineered vaccines have been anticipated for the prevention of leptospirosis in humans, but at present no commercial products of this kind are available. Protein antigens with high expression, extensive distribution and powerful antigenicity are extremely important for developing genetically engineered vaccines (Lin et al., 2011; Pinne et al., 2013) . LipL32, and then LipL21, have been confirmed to be highly expressed in different pathogenic leptospiral strains (Haake et al., 2000; Cullen et al., 2003) . A previous study reported that LipL32 is a submembrane lipoprotein of Leptospira (Pinne et al., 2013) . However, our previous analysis showed that LipL32 has six main surface membrane regions in its molecule (amino acids 75-80, 105-130, 150-180, 185-200, 210-220, and 245-255) (Luo et al., 2009 ). The MAT is an immunoagglutinative test using living leptospires as the antigens (Dong et al., 2008) . The MAT in this study showed that the rLipL32 antiserum agglutinated all the tested L. interrogans strains. In addition, a recent study has shown that LipL32 is exposed on the surface of leptospires to induce an inflammatory reaction through binding to Toll-like receptor-2 on HK2 human renal cells (Lo et al., 2013) . These data suggested that LipL32 or at least some regions of LipL32 are surface-exposed. Our recent study showed that OmpL1, Loa22 and LigB but not LenA are expressed by all the strains belonging to the 15 L. interrogans serovars prevailing in China. However, the low expression level of Loa22 and the high molecular weight of LigB (~220 kDa) limit them as immunogens for developing genetically engineered vaccines. Thus, we selected LipL32, LipL21, and OmpL1 to generate a fusion protein that can be used as a novel immunogen in a genetically engineered leptospirosis vaccine.
High expression of recombinant protein antigens is a key problem in the development of genetically engineered vaccines (Peleg et al., 2012) . In this study, we optimized the expression conditions of rLLO, which resulted in a 2.7-fold increase in the fusion protein yield compared to routine expression conditions. The Western blot assays confirmed that rLLO was recognizable by rLipL32/1, rLipL21 and rOmpL1/2 antisera, while rLLO antiserum also bound to rLipL32/1, rLipL21 and rOmpL1/2, indicating that rLLO maintained the immunogenicity of all three single-protein antigens. Furthermore, the rLLO antiserum showed stronger agglutination with all the tested standard strains belonging to L. interrogans, L. borgpetersenii and L. weilii than the rLipL32/1, rLipL21 and rOmpL1/2 antisera. The ELISA demonstrated that 98.5% of the serum samples from patients infected with L. interrogans serovars Lai, Grippotyphosa, Pomona and Autumnalis combined with rLLO. These data indicated that rLLO protein has stronger immunogenicity than separate LipL32/1, LipL21 and OmpL1/2. . L. interrogans serovar Grippotyphosa is also a common pathogen in China, while serovar Pomona is especially prevalent in North China (Zhang et al., 2012; Li et al., 2007) . The requirement for high production vaccine against leptospirosis is urgent; therefore, we selected the strains belonging to these three serovars that are most prevalent in China as challenges in the animal immunoprotective test. The results showed that rLLO provided higher immunoprotective rates (91.7%) against lethal infection with the different L. interrogans serovars than single rLipL32/1, rLipL21 or rOmpL1/2 (50.0-75.0%), probably due to the higher immunogenicity of a macromolecular fusion protein than a micromolecular single protein. Although the immunoprotective rates in the hamsters immunized by the mixture of rLipL32/1, rLipL21 and OmpL1/2 (83.3-91.7%) approached that by rLLO immunization, multiple expression and extraction of the three single protein antigens is less favorable for industrial production, Pathogenic Leptospira species can invade the lungs, liver and kidneys, but only remain in the animal kidney for a long period of time to discharge leptospires from urine during infection (Zhang et al., 2012) . Therefore, the culture of leptospires isolated from animal kidney tissue is a suitable method for assessing the elimination of leptospires achieved by the elicited immune response after vaccination. The results showed that no leptospires could be isolated from the kidneys of the surviving vaccinated hamsters after challenge. Moreover, the surviving rLLO-immunized hamsters also showed milder pulmonary, hepatic and renal injury compared to the dead non-immunized hamsters after challenge. Taking these findings together, rLLO can be used as an antigen for developing a novel universal genetically engineered vaccine that has high cross-protection against serovars of pathogenic leptospires that are prevalent in China. Ristow, P., P. Bourhy, F. W. da Cruz McBride, C. P. Figueira, M. Huerre, P. Ave, I.S. Girons, A. Ko and M. Picardeau. (2007) . The OmpA-like protein Loa22 is essential for leptospiral virulence. PLoS pathogens. 3, e97-106.
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SUPPLEMENTARY MATERIAL
MATERIALS AND METHODS
Variables used in central composite design (CCD)
Our preliminary experiments revealed that the major factors influencing the yields of the target recombinant protein rLipL32/1-LipL21-OmpL1/2 (rLLO) were the initial pH (H), duration before induction (D1), duration after induction (D2), concentration of isopropyl-β-D-thiogalactoside (IPTG) inducer (C) (Sigma, USA) and induction temperature (T). Based on these data and a previous report (Aravindan et al., 2007) , a CCD from response surface methodology (RSM) was used to optimize the protein expression conditions (Maldonado et al., 2007) . The selected independent variables and variable levels in CCD are listed in Table S1 . The CCD experimental scheme contained 52 assays including 42 factorial experiments and 10 duplicate tests at central points. LB medium was used to culture E. coli BL21DE3 pE-
Establishment of a mathematic model for predicting optimal expression conditions
The correlation between the actual yields of rLLO and their statistical coding values from the CCD expression assays were described as X i = A i -A 0 /ΔA (where X i is the variable coding value, A 0 is the actual value at the central point A i , and ΔA is the differential of the variable). Using the reported formula Y = b 0 + Sb i x i + Sb ii x 2 i + SSb ij x i x j (where Y is the response value, X i is the variable, b 0 is a constant, and b i , b ii , and b ij are the linear, square, and cross-product coefficients) as a basis (Aravindan et al., 2007) , a mathematic model was established to predict the optimal parameters during rLLO expression.
Statistical evaluation of the mathematical model
The validity of the mathematical model established to predict the optimal conditions for rLLO expression was determined by the change of determination coefficient (R 2 ) values and analysis of variance (ANOVA). A higher R 2 value indicates that the variation in the model is probably due to the change of variables, reflecting its feasibility and applicability (Wang et al., 2005) .
Measurement of rLLO yield
The rLLO expressed in E. coli was extracted using an Ni-NTA affinity chromatographic column (BioColor, China). The extracted rLLO was quantified using a BCA Protein Quantitative Kit (Beyotime Biotech, China) and then diluted with 0.01 M phosphate-buffered saline (pH 7.4). The dilutions with different rLLO concentrations were electrophoresed in sodium dodecyl sulfate polyacrylamide gel and then electron-transferred onto PVDF membrane (Millipore, USA). Using 1:1000 diluted rabbit anti-rLLO serum as the primary antibody and 1:3000 HRP-labeled goat anti-rabbit IgG (ImmunoResearch, USA) as the secondary antibody, several Western blot assays were performed and the immunoblotting bands were quantified by densitometry (gray-scale determination) using a Gel Image Analyzer (BioRad, USA). Based on the gray-scale values, a standard curve was constructed for the rLLO concentrations. The yields of rLLO in CCD expression assays were determined by Western blot assay and gray-scale values as above as well as calculations based on the rLLO concentration standard curve.
Medium selection
The type of medium can affect the growth of bacteria and cause changes in the rLLO yields. Therefore, SB, SOB, SOC, LB, YT, M9 and synthetic M9 media were selected to culture E. coli BL21DE3 pET42a-lipL32/1-lipL21-ompL1/2 under the optimal expression conditions, and the growth of the E. coli strain in different media was assessed by spectrophotometry at OD 600 . In addition, the effects of the glucose and sodium acetate concentrations in media and the amount of bacterial inoculation on the growth of the E. coli strain were also determined as above. One-way analysis of variance (ANOVA) was used to determine significant differences of the bacterial number in different media and culture conditions. Statistical significance was defined as p <0.05.
RESULTS
Major variables affecting the expression of rLLO
The yields of rLLO in the 10 duplicate tests at central points (43-52) were higher (33.20-41.43 mg/L) than in the 42 factorial experiments (1-42) (15.39-30.61 mg/L) (Table S2 ). ANOVA confirmed that the independent variables H, D1, T and D2 significantly influenced the yields (p <0.01 for H, D1, and T; p >0.05 for D2), but the independent variable C had no influence (Table S3) . However, the yields were significantly affected by different D1 and D2 values (p <0.01), indicating an interaction between the durations before and after induction (Table S3) .
High efficiency and reliability of the mathematical model
Based on the regression coefficients of the variables, a mathematical model was established to predict the optimal expression conditions of rLLO (FIG. S1) . The R 2 value of this model reached 87.83%, indicat- ing that it accurately predicted most of the protein yield variations. A high coincidence with a 96.34% degree of fitness between the predictive expression values and actual yields of rLLO was also found in the CCD-based expression assays (Table S4 and Fig.  S2 ).
Optimal expression conditions for rLLO
The results from RSM indicated that the highest yield (37.78 mg/L) of rLLO was obtained under the optimal expression conditions H = 7.9, D1 = 2.5 h, C = 0.2 mM, D2 = 5.83 h, and T = 31°C (Fig. S3) . However, the yield was low (13.95 mg/L) under routine expression conditions (H = 7.4, C = 1 mM, D1 = 2 h, D2 = 4 h, and T = 37°C).
Maximal bacterial growth in SB medium
Among the seven media tested, SB medium enabled E. coli BL21DE3 pET42a-lipL32/1-lipL21-ompL1/2 to reach maximal growth (FIG. S4) . However, 2-20% glucose, 0.05-0.25 mM sodium acetate, and 1-6% bacterial inoculation had no influence on bacterial growth (data not shown).
